China

6 Vaccines Approved for Use in China

Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
20 trials in 5 countries
Approval Source: reuters.com
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
13 trials in 6 countries
Approval Source: reuters.com
Inactivated

Shenzhen Kangtai Biological Products Co

KCONVAC

Approved in 2 countries
7 trials in 1 country
Approval Source: reuters.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: reuters.com
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: reuters.com

26 in Clinical Trials in China

Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
20 trials in 5 countries
Protein Subunit

Livzon Mabpharm Inc

V-01

7 trials in 3 countries
Protein Subunit

Sinocelltech

SCTV01C

12 trials in 2 countries
Protein Subunit

National Vaccine and Serum Institute

Recombinant SARS-CoV-2 Vaccine (CHO Cell)

Approved in 1 country
3 trials in 2 countries
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

7 trials in 4 countries
Protein Subunit

Clover

SCB-2019

12 trials in 11 countries
DNA

Inovio

INO-4800

9 trials in 9 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
RNA

Walvax

mRNA

4 trials in 3 countries
RNA

Pfizer/BioNTech

BNT162b1

5 trials in 3 countries
Non Replicating Viral Vector

CanSino

Ad5-nCoV-IH

3 trials in 3 countries
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
13 trials in 6 countries
Replicating Viral Vector

Wantai

DelNS1-2019-nCoV-RBD-OPT1

5 trials in 3 countries
Inactivated

Shenzhen Kangtai Biological Products Co

KCONVAC

Approved in 2 countries
7 trials in 1 country
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Protein Subunit

Livzon Pharmaceutical Group Inc

V-01-351/V-01D

Protein Subunit

Shanghai Zerun Biotechnology, Walvax Biotechnology

202-CoV

4 trials in 1 country
RNA

Stemirna Therapeutics Co Ltd

mRNACOVID-19 Vaccine

3 trials in 2 countries
Non Replicating Viral Vector

Shenzhen Geno-Immune Medical Institute

LV-SMENP

2 trials in 1 country
RNA

AIM Vaccine

LVRNA009

2 trials in 1 country
Non Replicating Viral Vector

AMMS

Ad5-nCoV

Replicating Viral Vector

Shenzhen Geno-Immune Medical Institute

Covid-19/aAPC

RNA

CSPC ZhongQi Pharmaceutical Technology

SYS6006

2 trials in 1 country
Inactivated

China National Biotec Group Company Limited

Omicron COVID-19 Vaccine (Vero Cell)

2 trials in 1 country